<bill session="115" type="s" number="252" updated="2019-04-18T16:32:31Z">
  <state datetime="2017-02-01">REFERRED</state>
  <status>
    <introduced datetime="2017-02-01"/>
  </status>
  <introduced datetime="2017-02-01"/>
  <titles>
    <title type="official" as="introduced">A bill to amend title XVIII of the Social Security Act to require drug manufacturers to provide drug rebates for drugs dispensed to low-income individuals under the Medicare prescription drug benefit program.</title>
    <title type="short" as="introduced">Medicare Drug Savings Act of 2017</title>
    <title type="short" as="introduced">Medicare Drug Savings Act of 2017</title>
    <title type="display">Medicare Drug Savings Act of 2017</title>
  </titles>
  <sponsor bioguide_id="N000032"/>
  <cosponsors>
    <cosponsor bioguide_id="B001230" joined="2017-02-01"/>
    <cosponsor bioguide_id="B001277" joined="2017-02-01"/>
    <cosponsor bioguide_id="B000944" joined="2017-02-01"/>
    <cosponsor bioguide_id="D000563" joined="2017-02-01"/>
    <cosponsor bioguide_id="F000457" joined="2017-02-01"/>
    <cosponsor bioguide_id="H001042" joined="2017-02-01"/>
    <cosponsor bioguide_id="K000383" joined="2017-02-01"/>
    <cosponsor bioguide_id="K000367" joined="2017-02-01"/>
    <cosponsor bioguide_id="L000174" joined="2017-02-01"/>
    <cosponsor bioguide_id="R000122" joined="2017-02-01"/>
    <cosponsor bioguide_id="S000033" joined="2017-02-01"/>
    <cosponsor bioguide_id="S001181" joined="2017-03-07"/>
    <cosponsor bioguide_id="S000770" joined="2017-02-01"/>
    <cosponsor bioguide_id="U000039" joined="2017-02-01"/>
    <cosponsor bioguide_id="W000802" joined="2017-02-01"/>
  </cosponsors>
  <actions>
    <action datetime="2017-02-01">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2017-02-01" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSFI" name="Senate Finance" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="s" session="115" relation="unknown" number="1511"/>
    <bill type="h" session="115" relation="unknown" number="1776"/>
    <bill type="s" session="115" relation="unknown" number="771"/>
    <bill type="s" session="115" relation="unknown" number="3411"/>
    <bill type="h" session="115" relation="unknown" number="4138"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Government information and archives"/>
    <term name="Health care costs and insurance"/>
    <term name="Inflation and prices"/>
    <term name="Medicaid"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
    <term name="Public contracts and procurement"/>
    <term name="Retail and wholesale trades"/>
  </subjects>
  <amendments/>
  <summary date="2017-02-01T05:00:00Z" status="Introduced in Senate">Medicare Drug Savings Act of 2017

This bill requires drug manufacturers to issue rebates to the Centers for Medicare &amp; Medicaid Services&#160;(CMS) for prescription drugs dispensed to eligible low-income individuals under the Medicare prescription drug benefit or a Medicare Advantage (MA) prescription drug plan (PDP).

Subject to civil monetary penalties, a Medicare or MA PDP sponsor must report,&#160;both to drug manufacturers and&#160;to the CMS, specified information related to the determination and payment of such rebates.</summary>
  <committee-reports/>
</bill>
